数学模型预测由快速和缓慢的细胞毒性T淋巴细胞杀死机制诱导的瘤控制模式
Yixuan Wang1, Daniel R Bergman1, Erica Trujillo2
1Department of Mathematics, University of Michigan, Ann Arbor, MI, 48109, USA.
Scientific reports
|December 18, 2023
概括
免疫检查点抑制剂 (ICI) 显示出有希望的结果,但低反应率仍然存在. 这项研究模拟了瘤-免疫动态,以确定影响ICI疗效的因素,并预测组合治疗策略,以获得更好的癌症治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 计算生物学 计算生物学
- 癌症研究 癌症研究
背景情况:
- 免疫疗法,特别是免疫检查点抑制剂 (ICI),已经彻底改变了癌症治疗.
- 然而,在许多癌症中,有限的应答率需要更深入地了解瘤与免疫相互作用.
- 细胞毒性T淋巴细胞 (CTLs) 使用穿孔素介导和Fas联体 (FasL) 驱动的途径来杀死瘤细胞,其机制偏好受瘤抗原性的影响.
研究的目的:
- 确定影响免疫检查点封锁反应的关键因素.
- 在PD-1/PD-L1阻塞下模拟体内瘤免疫动态.
- 预测可能对ICI有反应的患者群体,并探索组合治疗策略.
主要方法:
- 为瘤免疫动态构建一个普通微分方程模型.
- 模拟瘤生长,免疫细胞相互作用以及对PD-1/PD-L1阻塞的反应.
- 创建一个具有多种瘤和免疫特征的虚拟小鼠队列.
主要成果:
- 确定关键的瘤和免疫景观特征,影响短期和长期的瘤大小和组成.
- 与瘤消除,休眠和逃逸相关的因素的表征.
- 在异质人群中预测应答者分数.
结论:
- 这项研究提供了关于控制ICI反应的复杂瘤免疫相互作用的见解.
- 确定了预测ICI疗效的关键特征,有助于患者分层.
- 建模表明潜在的组合疗法,以提高不响应或部分响应的患者群体的治疗结果.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529


